MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ALXO has $178,328K in assets. $26,981K in debts. $32,284K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
721.40%
Quick Ratio
721.40%
Cash Ratio
160.00%
Debt to Asset Ratio
15.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Long-term investments
    • Less accumulated depreciation
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Term loan, current
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
32,284 16,373 23,442 19,302
Short-term investments
108,040 28,417 37,184 60,012
Prepaid expenses and other current assets
5,240 5,937 5,890 5,943
Total current assets
145,564 50,727 66,516 85,257
Property and equipment, gross
3,134 3,179 3,179 -
Less accumulated depreciation
2,084 1,979 1,828 -
Property and equipment, net
1,050 1,200 1,351 1,497
Long-term investments
28,783 3,494 5,838 4,232
Other assets
2,931 3,625 9,018 4,334
Total assets
178,328 59,046 82,723 95,320
Accounts payable
3,854 4,914 6,583 4,902
Payable and accrued liabilities due to related party
-0 0 40
Term loan, current
5,217 5,217 4,348 3,043
Accrued expenses and other current liabilities
11,107 14,422 16,791 10,863
Total current liabilities
20,178 24,553 27,722 18,848
Total term loan, net of current portion
3,644 ---
Less unamortized debt issuance costs
269 ---
Less unaccreted final payment costs
80 ---
Term loan, non-current
3,295 4,532 5,764 6,997
Other non-current liabilities
3,508 3,980 4,437 5,060
Total liabilities
26,981 33,065 37,923 30,905
Common stock, 0.001 par value 1,000,000,000 shares authorized as of march 31, 2026 and december 31, 2025 134,540,741and 54,388,022 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
135 54 54 54
Additional paid-in capital
892,201 748,716 744,672 742,150
Accumulated other comprehensive income
-245 28 43 36
Accumulated deficit
-740,744 -722,817 -699,969 -677,825
Total stockholders equity
151,347 25,981 44,800 64,415
Total liabilities and stockholders equity
178,328 59,046 82,723 95,320
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$108,040K Cash and cashequivalents$32,284K Prepaid expenses andother current assets$5,240K Property and equipment,gross$3,134K Total current assets$145,564K Long-term investments$28,783K Other assets$2,931K Property and equipment,net$1,050K Less accumulateddepreciation$2,084K Total assets$178,328K Total liabilities andstockholders equity$178,328K Total stockholdersequity$151,347K Total liabilities$26,981K Accumulated deficit-$740,744K Accumulated othercomprehensive income-$245K Additional paid-in capital$892,201K Total currentliabilities$20,178K Other non-currentliabilities$3,508K Term loan,non-current$3,295K Common stock, 0.001 parvalue 1,000,000,000...$135K Less unamortizeddebt issuance costs$269K Less unaccretedfinal payment costs$80K Accrued expenses andother current...$11,107K Term loan, current$5,217K Accounts payable$3,854K Total term loan, net ofcurrent portion$3,644K

ALX ONCOLOGY HOLDINGS INC (ALXO)

ALX ONCOLOGY HOLDINGS INC (ALXO)